Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Dupilumab Improves Esophageal Distensibility in Eosinophilic Esophagitis

Dupilumab Improves Esophageal Distensibility in Eosinophilic Esophagitis
ShareXFacebook

(MedPage Today) -- The monoclonal antibody dupilumab (Dupixent) led to significant improvements in esophageal distensibility among patients with eosinophilic esophagitis, the randomized REMODEL trial showed. At 24 weeks, patients taking dupilumab...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

FDA Wants Better Pregnancy Safety Data on Approved Drugs
MedPage Today

FDA Wants Better Pregnancy Safety Data on Approved Drugs

(MedPage Today) -- The FDA on Friday issued guidance for manufacturers collecting postmarketing data on the safety of approved drugs and biologics in pregnancy, with the goal of better understanding potential risks for the pregnant patient and...

Read more →
Advertisement